Improved risk assessment using a novel cancer-specific biomarker assay derived from autoantibody signatures for men with non-aggressive prostate cancer who are not receiving treatment

Biomedical Research and Reviews(2017)

引用 0|浏览6
暂无评分
关键词
prostate cancer-specific,biomarker,autoantibody signatures,risk assessment,non-aggressive
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要